# The Medicines (Products for Human Use-Fees) Regulations 2008, Regulation 8: Fee for advice on labelling or leaflets


Unless regulation 44 applies, the fee payable by the holder of one or more marketing authorizations with whom the licensing authority holds a meeting in order to provide advice on proposed changes to the labelling or the package leaflets of the medicinal products to which those authorizations relate, is £2,227.

---
Source: https://www.legislation.gov.uk/uksi/2008/552/regulation/8 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2008/regulation-8
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.